LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Article ; Online: FXTAS Neuropathology Includes Widespread Reactive Astrogliosis and White Matter Specific Astrocyte Degeneration.

    Dufour, Brett D / Bartley, Trevor / McBride, Erin / Allen, Erik / McLennan, Yingratana A / Hagerman, Randi J / Martínez-Cerdeño, Verónica

    Annals of neurology

    2024  Volume 95, Issue 3, Page(s) 558–575

    Abstract: Objective: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset progressive genetic neurodegenerative disorder that occurs in FMR1 premutation carriers. The temporal, spatial, and cell-type specific patterns of neurodegeneration in the ... ...

    Abstract Objective: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset progressive genetic neurodegenerative disorder that occurs in FMR1 premutation carriers. The temporal, spatial, and cell-type specific patterns of neurodegeneration in the FXTAS brain remain incompletely characterized. Intranuclear inclusion bodies are the neuropathological hallmark of FXTAS, which are largest and occur most frequently in astrocytes, glial cells that maintain brain homeostasis. Here, we characterized neuropathological alterations in astrocytes in multiple regions of the FXTAS brain.
    Methods: Striatal and cerebellar sections from FXTAS cases (n = 12) and controls (n = 12) were stained for the astrocyte markers glial fibrillary acidic protein (GFAP) and aldehyde dehydrogenase 1L1 (ALDH1L1) using immunohistochemistry. Reactive astrogliosis severity, the prevalence of GFAP+ fragments, and astrocyte density were scored. Double label immunofluorescence was utilized to detect co-localization of GFAP and cleaved caspase-3.
    Results: FXTAS cases showed widespread reactive gliosis in both grey and white matter. GFAP staining also revealed remarkably severe astrocyte pathology in FXTAS white matter - characterized by a significant and visible reduction in astrocyte density (-38.7% in striatum and - 32.2% in cerebellum) and the widespread presence of GFAP+ fragments reminiscent of apoptotic bodies. White matter specific reductions in astrocyte density were confirmed with ALDH1L1 staining. GFAP+ astrocytes and fragments in white matter were positive for cleaved caspase-3, suggesting that apoptosis-mediated degeneration is responsible for reduced astrocyte counts.
    Interpretation: We have established that FXTAS neuropathology includes robust degeneration of astrocytes, which is specific to white matter. Because astrocytes are essential for maintaining homeostasis within the central nervous system, a loss of astrocytes likely further exacerbates neuropathological progression of other cell types in the FXTAS brain. ANN NEUROL 2024;95:558-575.
    MeSH term(s) Humans ; Astrocytes/metabolism ; Tremor/genetics ; Gliosis/pathology ; Caspase 3/metabolism ; White Matter/pathology ; Fragile X Syndrome/diagnosis ; Fragile X Syndrome/genetics ; Fragile X Syndrome/metabolism ; Ataxia/genetics ; Fragile X Mental Retardation Protein/genetics
    Chemical Substances Caspase 3 (EC 3.4.22.-) ; Fragile X Mental Retardation Protein (139135-51-6) ; FMR1 protein, human
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26851
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked

    Napoli, Eleonora / McLennan, Yingratana Amabel / Schneider, Andrea / Tassone, Flora / Hagerman, Randi J / Giulivi, Cecilia

    Frontiers in molecular biosciences

    2020  Volume 7, Page(s) 578640

    Abstract: ... The X- ... ...

    Abstract The X-linked
    Language English
    Publishing date 2020-10-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2020.578640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

    Salcedo-Arellano, Maria Jimena / Johnson, Michael D / McLennan, Yingratana A / Hwang, Ye Hyun / Juarez, Pablo / McBride, Erin Lucille / Pantoja, Adriana P / Durbin-Johnson, Blythe / Tassone, Flora / Hagerman, Randi J / Martínez-Cerdeño, Verónica

    Cells

    2023  Volume 12, Issue 17

    Abstract: The course of pathophysiological mechanisms involved in fragile X-associated tremor/ataxia syndrome (FXTAS) remains largely unknown. Previous proteomics and metabolomics studies conducted in blood samples collected ... ...

    Abstract The course of pathophysiological mechanisms involved in fragile X-associated tremor/ataxia syndrome (FXTAS) remains largely unknown. Previous proteomics and metabolomics studies conducted in blood samples collected from
    MeSH term(s) Humans ; Tremor ; Brain ; Cytidine ; Cytosine ; Guanine ; Metabolomics ; Ataxia/genetics ; Fragile X Mental Retardation Protein/genetics
    Chemical Substances Cytidine (5CSZ8459RP) ; Cytosine (8J337D1HZY) ; Guanine (5Z93L87A1R) ; FMR1 protein, human ; Fragile X Mental Retardation Protein (139135-51-6)
    Language English
    Publishing date 2023-08-23
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells12172132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS.

    Wang, Junyi / Napoli, Eleonora / Kim, Kyoungmi / McLennan, Yingratana A / Hagerman, Randi J / Giulivi, Cecilia

    International journal of molecular sciences

    2021  Volume 22, Issue 17

    Abstract: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder affecting subjects (premutation carriers) with a 55-200 CGG-trinucleotide expansion in the 5'UTR of the fragile X mental retardation 1 gene ( ...

    Abstract Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder affecting subjects (premutation carriers) with a 55-200 CGG-trinucleotide expansion in the 5'UTR of the fragile X mental retardation 1 gene (
    MeSH term(s) Adenosine Triphosphate/metabolism ; Adult ; Aged ; Aging/metabolism ; Ataxia/diagnostic imaging ; Ataxia/metabolism ; Brain/diagnostic imaging ; Brain/growth & development ; Cells, Cultured ; Energy Metabolism ; Female ; Flavin-Adenine Dinucleotide/analogs & derivatives ; Flavin-Adenine Dinucleotide/metabolism ; Fragile X Mental Retardation Protein/genetics ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/diagnostic imaging ; Fragile X Syndrome/metabolism ; Humans ; Male ; Middle Aged ; Mitochondria/metabolism ; Monocytes/metabolism ; Tremor/diagnostic imaging ; Tremor/metabolism ; White Matter/diagnostic imaging ; White Matter/growth & development
    Chemical Substances FMR1 protein, human ; Fragile X Mental Retardation Protein (139135-51-6) ; Flavin-Adenine Dinucleotide (146-14-5) ; 1,5-dihydro-FAD (1910-41-4) ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2021-08-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22179171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome.

    Johnson, Devon / Santos, Ellery / Kim, Kyoungmi / Ponzini, Matthew D / McLennan, Yingratana A / Schneider, Andrea / Tassone, Flora / Hagerman, Randi J

    Frontiers in psychiatry

    2022  Volume 12, Page(s) 762915

    Abstract: Individuals with the fragile X premutation report symptoms of chronic pain from multiple systems, have increased incidence of comorbid conditions where pain is a prominent feature, and pathophysiology that supports disrupted pain regulation, inflammation, ...

    Abstract Individuals with the fragile X premutation report symptoms of chronic pain from multiple systems, have increased incidence of comorbid conditions where pain is a prominent feature, and pathophysiology that supports disrupted pain regulation, inflammation, and energy imbalance. Less is known about how pain manifests for the subpopulation of carriers that develop the motor and cognitive changes of fragile X-associated tremor and ataxia syndrome (FXTAS), and how pain may differ between men and women. We gathered data collected from 104 males and females with FXTAS related to chronic pain, comorbid conditions related to pain, and medications used for pain control to further explore the types of pain experienced and to better characterize how individuals with the fragile X premutation experience pain sensation across genders. We found that women experience significantly more pain symptoms than men, particularly allodynia (20 vs. 2.0%,
    Language English
    Publishing date 2022-01-20
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2021.762915
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Fragile X syndrome and associated disorders: Clinical aspects and pathology.

    Salcedo-Arellano, Maria Jimena / Dufour, Brett / McLennan, Yingratana / Martinez-Cerdeno, Veronica / Hagerman, Randi

    Neurobiology of disease

    2020  Volume 136, Page(s) 104740

    Abstract: This review aims to assemble many years of research and clinical experience in the fields of neurodevelopment and neuroscience to present an up-to-date understanding of the clinical presentation, molecular and brain pathology associated with Fragile X ... ...

    Abstract This review aims to assemble many years of research and clinical experience in the fields of neurodevelopment and neuroscience to present an up-to-date understanding of the clinical presentation, molecular and brain pathology associated with Fragile X syndrome, a neurodevelopmental condition that develops with the full mutation of the FMR1 gene, located in the q27.3 loci of the X chromosome, and Fragile X-associated tremor/ataxia syndrome a neurodegenerative disease experienced by aging premutation carriers of the FMR1 gene. It is important to understand that these two syndromes have a very distinct clinical and pathological presentation while sharing the same origin: the mutation of the FMR1 gene; revealing the complexity of expansion genetics.
    MeSH term(s) Animals ; Ataxia/genetics ; Ataxia/metabolism ; Ataxia/pathology ; Fragile X Mental Retardation Protein/genetics ; Fragile X Mental Retardation Protein/metabolism ; Fragile X Syndrome/genetics ; Fragile X Syndrome/metabolism ; Fragile X Syndrome/pathology ; Humans ; Neurodegenerative Diseases/genetics ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/pathology ; Tremor/genetics ; Tremor/metabolism ; Tremor/pathology
    Chemical Substances FMR1 protein, human ; Fragile X Mental Retardation Protein (139135-51-6)
    Language English
    Publishing date 2020-01-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1211786-9
    ISSN 1095-953X ; 0969-9961
    ISSN (online) 1095-953X
    ISSN 0969-9961
    DOI 10.1016/j.nbd.2020.104740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series.

    Salcedo-Arellano, Maria Jimena / Cabal-Herrera, Ana Maria / Tassanakijpanich, Nattaporn / McLennan, Yingratana A / Hagerman, Randi J

    Biomedicines

    2020  Volume 8, Issue 5

    Abstract: Fragile X-associated tremor and ataxia syndrome (FXTAS) is a neurodegenerative disease developed by carriers of a premutation in the fragile X mental retardation 1 ( ...

    Abstract Fragile X-associated tremor and ataxia syndrome (FXTAS) is a neurodegenerative disease developed by carriers of a premutation in the fragile X mental retardation 1 (
    Language English
    Publishing date 2020-05-25
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines8050136
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS

    Junyi Wang / Eleonora Napoli / Kyoungmi Kim / Yingratana A. McLennan / Randi J. Hagerman / Cecilia Giulivi

    International Journal of Molecular Sciences, Vol 22, Iss 9171, p

    2021  Volume 9171

    Abstract: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder affecting subjects (premutation carriers) with a 55-200 CGG-trinucleotide expansion in the 5′UTR of the fragile X mental retardation 1 gene ( FMR1 ) typically after age ... ...

    Abstract Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder affecting subjects (premutation carriers) with a 55-200 CGG-trinucleotide expansion in the 5′UTR of the fragile X mental retardation 1 gene ( FMR1 ) typically after age 50. As both the presence of white matter hyperintensities (WMHs) and atrophied gray matter on magnetic resonance imaging (MRI) are linked to age-dependent decline in cognition, here we tested whether MRI outcomes (WMH volume (WMHV) and brain volume) were correlated with mitochondrial bioenergetics from peripheral blood monocytic cells in 87 carriers with and without FXTAS. As a parameter assessing cumulative damage, WMHV was correlated to both FXTAS stages and age, and brain volume discriminated between carriers and non-carriers. Similarly, mitochondrial mass and ATP production showed an age-dependent decline across all participants, but in contrast to WMHV, only FADH 2 -linked ATP production was significantly reduced in carriers vs. non-carriers. In carriers, WMHV negatively correlated with ATP production sustained by glucose-glutamine and FADH 2 -linked substrates, whereas brain volume was positively associated with the latter and mitochondrial mass. The observed correlations between peripheral mitochondrial bioenergetics and MRI findings—and the lack of correlations with FXTAS diagnosis/stages—may stem from early brain bioenergetic deficits even before overt FXTAS symptoms and/or imaging findings.
    Keywords aging ; cognition ; brain ; MRI ; volume ; white matter hyperintensities ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 610
    Language English
    Publishing date 2021-08-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome.

    Salcedo-Arellano, Maria Jimena / Sanchez, Desiree / Wang, Jun Yi / McLennan, Yingratana A / Clark, Courtney Jessica / Juarez, Pablo / Schneider, Andrea / Tassone, Flora / Hagerman, Randi J / Martínez-Cerdeño, Verónica

    Frontiers in neuroscience

    2021  Volume 15, Page(s) 720253

    Abstract: This case documents the co-occurrence of the fragile X-associated tremor ataxia syndrome (FXTAS) and Alzheimer-type neuropathology in a 71-year-old premutation carrier with 85 CGG repeats in the fragile X mental retardation 1 ( ...

    Abstract This case documents the co-occurrence of the fragile X-associated tremor ataxia syndrome (FXTAS) and Alzheimer-type neuropathology in a 71-year-old premutation carrier with 85 CGG repeats in the fragile X mental retardation 1 (
    Language English
    Publishing date 2021-09-17
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2411902-7
    ISSN 1662-453X ; 1662-4548
    ISSN (online) 1662-453X
    ISSN 1662-4548
    DOI 10.3389/fnins.2021.720253
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression.

    McLennan, Yingratana A / Mosconi, Matthew W / McKenzie, Forrest J / Famula, Jessica / Krawchuk, Bennet / Kim, Kyoungmi / Clark, Courtney J / Hessl, David / Rivera, Susan M / Simon, Tony J / Tassone, Flora / Hagerman, Randi J

    Movement disorders clinical practice

    2022  Volume 9, Issue 4, Page(s) 473–478

    Abstract: Background: Quantitative measurement of eye movements can reveal subtle progression in neurodegenerative diseases.: Objective: To determine if quantitative measurements of eye movements may reveal subtle progression of fragile X-associated tremor and ...

    Abstract Background: Quantitative measurement of eye movements can reveal subtle progression in neurodegenerative diseases.
    Objective: To determine if quantitative measurements of eye movements may reveal subtle progression of fragile X-associated tremor and ataxia (FXTAS).
    Methods: Prosaccade (PS) and antisaccade (AS) behavior was analyzed in 25 controls, 57 non-FXTAS carriers, and 46 carriers with FXTAS.
    Results: Symptomatic individuals with FXTAS had longer AS latencies, increased rates of AS errors, and increased AS dysmetria relative to non-FXTAS carriers and controls. These deficits, along with PS latency and velocity, were greater in advanced FXTAS stages.
    Conclusion: AS deficits differentiated FXTAS from non-FXTAS premutation carriers implicating top-down control and frontostriatal deterioration. However, the absence of group differences between non-FXTAS carriers and controls in AS and PS markers suggests saccade performance may not be a sensitive enough measure for detecting conversion to FXTAS, but instead more helpful as translational biomarkers of FXTAS progression.
    Language English
    Publishing date 2022-04-28
    Publishing country United States
    Document type Journal Article
    ISSN 2330-1619
    ISSN (online) 2330-1619
    DOI 10.1002/mdc3.13449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top